CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
EUFLEXXAdrug
Likely dose
EUFLEXXA 2.5 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00969501
NCT00969501N/ACompleted
CompareCT.gov

Investigator Initiated, Exploratory Case Study Three Injections of EUFLEXXA (Sodium Hyaluronate)Treatment of Chronic Shoulder Pain Associated With Osteoarthritis

Georgia Institute for Clinical Research, LLC·interventional·Posted Sep 1, 2009·Updated May 7, 2013

In Brief

A clinical study evaluating EUFLEXXA for Osteoarthritis. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The hypothesis of this study is that by using 3 injections of EUFLEXXA, there will be an improvement in pain levels and range of motion.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis
CountriesUnited States
CollaboratorsFerring Pharmaceuticals

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 1, 2009
Enrollment StartAug 1, 2009
Primary CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 16.8 years ago

Interventions

EUFLEXXAdrug

2.5 mL of EUFLEXXA (per injection) x 3 injections